Plazmid DNA Transfeksiyonu ve mRNA Nükleofeksiyon Dağıtımı Kullanılarak İnsan Hücrelerinde CRISPR Epigenom Düzenleme

Overview

This protocol describes methods for delivering epigenomic editors into human cells using CRISPR-based techniques. By fusing chromatin effectors to dCas9, targeted gene modulation can be achieved without introducing toxic DNA breaks.

Key Study Components

Area of Science

• Neuroscience
• Genetics
• Cell Biology

Background

• Efficient delivery of epigenome editors into cells is a significant challenge.
• Maintaining precise target specificity is crucial for successful gene modulation.
• Stable or transient gene repression can be difficult to achieve.
• This protocol avoids cleaving mechanisms to reduce toxicity and genomic instability.

Purpose of Study

• To design and deliver epigenomic editors into human cells.
• To enable targeted gene modulation without toxic DNA breaks.
• To provide methods for controlled gene expression modulation.

Methods Used

• Plasmid DNA transfection
• mRNA nucleofection
• Fusion of chromatin effectors to dCas9
• Avoidance of cleaving mechanisms

Main Results

• Successful delivery of epigenome editors into human cells.
• Targeted gene modulation achieved without introducing DNA breaks.
• Reduction in toxicity and genomic instability observed.
• Methods allow for controlled gene expression modulation.

Conclusions

• This protocol provides effective methods for epigenome editing.
• It addresses key challenges in gene modulation techniques.
• Future applications may enhance gene therapy approaches.

Frequently Asked Questions